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Outrunning Salmonella – a role of endogenous Enterobacteriaceae 
in variable colonization resistance   
 
The mammalian gut microbiota confers colonization resistance against 
pathogenic bacteria. Specific pathogen-free C57BL/6 mice from different 
vendors are variably resistant to oral non-typhoidal Salmonella infection. 
New work shows that differences in endogenous Enterobacteriaceae 
determine this phenotypic variability.  
 
Siegfried Hapfelmeier-Balmer 
 
The mouse model of non-typhoidal Salmonella infection is a prime example of the 
microbiota-related phenotypic variability of mouse models. As first demonstrated by studies 
in which antibiotics were administered to mice, an intact gut microbiota confers resistance 
against intestinal colonization of non-typhoidal Salmonella and subsequent intestinal and 
systemic infection. More recent work has established that Salmonella actively induces 
microbiota alterations to shape a favorable intestinal niche. Acute Salmonella-induced 
intestinal inflammation abolishes colonization resistance 2, by specifically generating electron 
acceptors for the anaerobic respiration of Salmonella while damaging the integrity of the 
competing anaerobic gut consortia 3. However, Salmonella has first to reach a critical 
intestinal density to induce the acute inflammatory disease. Bäumler and colleagues have 
worked out previously that the early intestinal bloom of Salmonella is fueled by aerobic 
respiration, which is enhanced by virulence factor-induced microaerophilic conditions 4. 
Recent experimental evidence supports that commensal facultative aerobic bacteria 
including Enterobacteriaceae have an important protective function by blooming under the 
same microaerophilic conditions and outcompeting Salmonella 5,6 (Fig. 1). 
 
Velazquez and colleagues 7 now show that endogenous facultative aerobes also underlie 
the variation in susceptibility to Salmonella enterica serovar Typhimurium (S. Typhimurium) 
of unmanipulated specific pathogen-free (SPF) mice from different vendors. Through 
transplantation of SPF microbiotas into germ-free mice, they prove that gut microbiota rather 
than host genome variability between the different C57BL/6 substrains explains their 
variability in susceptibility to oral Salmonella. Using a combination of unbiased DNA 
sequencing-based microbiome profiling and selective culture techniques, the authors found 
a strong correlation between Salmonella resistance and the abundance of 
Enterobacteriaceae. The authors also confirmed causality, according to Koch’s postulates, 
by showing that inoculation of Salmonella-susceptible mice with Enterobacteriaceae isolated 
from more highly colonization resistant mice conferred resistance to the susceptible mice. 
Finally, they carried out a similar experiment using the well-characterized probiotic E. coli 
strain Nissle. Wild-type E. coli Nissle, but not an isogenic mutant deficient for aerobic 
respiration under microaerophilic conditions, conferred resistance. Although the authors did 
not make isogenic mutants of murine Enterobacteriaceae isolated in the present study, this 
result strongly suggests that a similar metabolic mechanism underlies the effect of the 
relevant endogenous Enterobacteriaceae. Velazquez and colleagues focused their 
mechanistic studies on the Enterobacteriaceae; however, they found that the 
Deferribacteriaceae family was also positively associated with Salmonella resistance. 
Interestingly, a recent study by Stecher and colleagues independently showed that the 
Altered Schaedler Flora strain Mucospirillum schaedleri, a representative of the 
Deferribacteriaceae, contributes to protection from S. Typhimurium by competing for 
terminal electron receptors 8. 
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Outstanding questions remain. How generalizable are these findings with regards to other 
infectious diseases? Head-to-head comparisons of this model and other infection models, 
for example of the facultative aerobes Citrobacter rodentium and Vibrio cholerae, are 
currently lacking. How relevant is this mouse study for human biology or veterinary 
medicine? E. coli is commonly viewed as an important human, but not murine, 
commensal/symbiont, and hence translatability of E. coli work in the mouse model is 
sometimes questioned. Most well-studied E. coli strains (including Nissle) are of human 
origin, whereas murine isolates and their mouse-specific adaptations remain poorly 
characterized. A more general point is that the gut microbiota composition of laboratory mice 
is overall very different from feral mice, and has been made partly responsible for the 
phenotypic differences between human and laboratory mouse immunity and disease 
resistance 9,10. Commonly used inbred laboratory mouse lines, such as C57BL/6 or BALB/C, 
were separated from free-living populations many decades ago, and since then have been 
maintained in fairly closed and artificial environments, with monotonous laboratory rodent 
diet, and with limited or no (in strict barrier facilities) input of environmental microbes, in 
particular of murine origin. Intestinal species diversity loss and transfer of human microbial 
contaminants (from animal caretaker personnel) might therefore be hallmarks of lab rodent 
microbiota evolution. Maintaining mice in barrier facilities of “optimal” hygiene status 
certainly helps to prevent infection of experimental animal stocks with known and unknown 
pathogens. However, the resulting loss of symbiotic species is usually not actively 
compensated.  
 
The work of Velazquez and colleagues has two additional implications in biomedical 
research areas that can be affected by microbiota-related phenotypic variability. First, 
microbiota variability in lowly abundant taxa might underlie phenotypic variability and escape 
detection by microbiota compositional analyses of limited depth or inappropriate design. 
Second, the study of Velazquez et al. exemplifies that it can be difficult to clarify whether 
host genome or microbiome contribute mainly to a biological phenotype: as shown, simple 
co-housing of adult animal cohorts is often ineffective at equalizing the gut consortia, whose 
ontogeny is subject to early life ecological successions. The current gold standards are fecal 
microbiota transplantation into germ-free mice or embryo transfer derivation of a mouse line. 
Littermate control breeding and litter swap experiments in which the animal lines to be 
compared are nursed by the same parents are less rigorous approaches to equalize 
microbiota. The growing number of biological functions and diseases shown to be influenced 
by the microbiota underscores that continued efforts are needed to better standardize not 
only the genomes, but also the microbiomes of experimental animals to improve 
reproducibility in biomedical research. The control of host genome variability is already 
standard today, as most researchers rely on isogenic inbred rodent lines; the standardization 
of microbiome studies, by contrast, is still in its infancy. Gnotobiotic animals, generated from 
germ-free animals by colonization with defined bacterial species, are a powerful tool to 
control the microbiota 5.  However, besides facing the issues of costs and infrastructure 
availability, we are still far from having available gnotobiotic models that fully reproduce the 
functional complexity of natural microbiomes. 
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Fig 1| . Protective Enterobacteriaceae bloom. a, Microbiota lacking Enterobacteriaceae. 
Salmonella overgrowth (red curve) in the progressively inflamed gut is fueled by 
microaerophilic and anaerobic respiration. b, Microbiota containing Enterobacteriaceae. A 
bloom of endogenous commensal Enterobacteriaceae (green curve), also driven by 
microaerophilic respiration, might outcompete Salmonella (red curve). 
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i. Anaerobe phase (fueled by what? No inflammation yet)
ii. Microaerobic respiratory phase (mild inflammation)
iii. Anaerobic respiratory phase (acute inflammation)
i. Anaerobe phase (limited by what?)
ii. Microaerobic respiratory phase (mildly inflamed)
and Outcompetition by Enterobacteriaceae
i. Anaerobe phase (baseline colonization)
ii. Microaerobic respiratory phase (protective bloom)
iii. Recovery of anaerobiosis and return to homeostasis
i. ii. iii.
i. ii. iii.
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